RPC1063
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The central nervous system is characterized by a high content of sphingolipids and by a high diversity in terms of different…
Ozanimod (RPC1063) is a specific and potent small molecule modulator of the sphingosine 1-phosphate receptor 1 (S1PR1) and…
The introduction of oral disease modifying therapies has transformed the treatment landscape for patients with multiple sclerosis…
Sphingosine 1-phosphate receptor (S1PR) modulators possess a unique mechanism of action in the treatment of multiple sclerosis…
Sphingosine1‐phosphate (S1P) receptors mediate multiple events including lymphocyte trafficking, cardiac function, and…
BACKGROUND
Ozanimod (RPC1063) is an oral agonist of the sphingosine-1-phosphate receptor subtypes 1 and 5 that induces peripheral…
Sphingosine 1-phosphate (S1P) receptor modulators possess a unique mechanism of action as disease-modifying therapy for multiple…
Digestive Disease Week (DDW) 2015 will take place in Washington, DC, from May 17 to 19. With more than 400 scientific sessions…